Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00190567 · ClinicalTrials.gov registry record · Phase 2
Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in Women in Pure Genuine Stress Incontinence
A Phase 2 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
NCT00190567 is a Phase 2 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 50 participants.
The verdict
NCT00190567, a Phase 2 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
Study Summary
Double-blind placebo-controlled study of the biomechanical effects of duloxetine compared with placebo in the treatment of women with pure genuine stress incontinence
Interventions
- DRUG Placebo
- DRUG duloxetine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2001-10 |
| Est. Completion | 2006-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00190567
The ClinicalTrials.gov registry entry for NCT00190567 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00190567 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00190567 about?
NCT00190567 is a clinical study titled "Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in Women in Pure Genuine Stress Incontinence". Double-blind placebo-controlled study of the biomechanical effects of duloxetine compared with placebo in the treatment of women with pure genuine stress incontinence
What is the current status of trial NCT00190567?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2001-10. Estimated completion is 2006-04.
What interventions are being tested in trial NCT00190567?
The interventions under investigation include: Placebo (DRUG), duloxetine (DRUG).
Who is sponsoring clinical trial NCT00190567?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.